IFIH1 and interstitial lung disease: Although this meta-analysis specifically focused on MDA5+ DM-ILD patients, it is noteworthy that a recently reported case described an anti-MDA5 antibody-negative JDM patient who developed fatal RP-ILD within 1.5 months of diagnosis (42).